GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...

Novo Nordisk has launched its weight-loss drug Wegovy in India, while Eli Lilly's Mounjaro has received regulatory approval, ...

Dr. Ambish Mithal unpacks the world of new-age weight management drugs, their side effects, their benefits and what lies ...

Joie Armstrong asked her doctor about taking a GLP-1 medication to help her lose weight six times before she got a prescription, and then was denied coverage by her insurance company. Adrian, a ...

A new study has been launched into the side effects of weight loss and diabetes jabs after hundreds of cases of pancreatitis ...

This season, authors provide advice on managing ailments new and old, from climate anxiety and digital overwhelm to chronic ...

A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.

Refusing the subscription would be a good test of the friendship. If it continues, your friend is friends with you for who you are. If refusal affects your relationship, it shows that your friend is ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

Migraines are a common ailment worldwide, affecting nearly 15% of the global population. At times, they can be debilitating enough to interfere with daily activities. Despite a multitude of treatment ...

Novo Nordisk AS and a group of insurers will pay $32 million to end litigation over its $1.8 billion acquisition of ...